OHSU’s School of Medicine announces upcoming 125th Anniversary lectures
05/16/13 Portland, Ore.
During Oregon Health & Science University's upcoming 125th anniversary lectures, award-winning speakers will explore the future of discovery, education and outreach in health care. Thinking creatively about how technology, innovation and collaboration can transform health care, these speakers will encourage compelling conversations about the role of academic medicine in the 21st century and beyond. The list of lectures, hosted by the School of Medicine, is below.
All lectures are free and open to the public.
Lectures begin at 12 p.m. Dates vary; see below
OHSU Auditorium (Old Library building), 3181 S.W. Sam Jackson Park Road, Portland, Ore.
Tuesday, May 21, 2013
Mace L. Rothenberg, M.D., senior vice president of clinical development and medical affairs, Pfizer
Industry-academia collaboration: Developing novel therapeutics in oncology based on new genetic insights
Mace L. Rothenberg, M.D., will speak about the growing importance of the collaboration between industry and academia for discovery and drug development, using examples stemming from novel therapeutics in oncology and based on new genetic insights. Dr. Rothenberg is responsible for overseeing clinical research and developing activities as well as post-marketing evaluation and monitoring for all Pfizer oncology products. Dr. Rothenberg came to Pfizer in 2008 after more than 20 years in academia where he focused on early-stage drug development, clinical trial design and the coordinated laboratory-clinical evaluation of new therapies for gastrointestinal cancers. He is the recipient of the American Cancer Society's Lane W. Adams Quality of Life Award, honoring him as one of the nation's top cancer caregivers and the American Society of Clinical Oncology's Statesman Award, honoring him for more than 20 years of service to the organization, oncology and cancer patients. Dr. Rothenberg’s lecture is also part of OHSU Research Week.
Wednesday, June 12, 2013
Eric Topol, M.D., director, Scripps Translational Science Institute, author
How digitizing human beings reboots the future of medicine
Will we soon be checking vital signs on our phones? Pioneering geneticist and cardiologist Eric Topol, M.D., will share his perspective on the coming era of "big data" and the transformative impact of the digitization of medicine, focusing on the convergence of genomics and innovative wireless health care "apps" — a topic covered in his recent book, The Creative Destruction of Medicine. Dr. Topol is currently the director of the Scripps Translational Science Institute in La Jolla, Calif., where he also holds an endowed chair of innovative medicine. Previously, he was chief of cardiovascular medicine at the Cleveland Clinic, a 2009 TEDMED speaker, and named the #1 Most Influential Physician Executive in 2012 by Modern Healthcare.
Oregon Health & Science University is the state's only public academic health and research university. As one of Oregon's largest employers with more than 14,000 employees, OHSU's size contributes to its ability to provide many services and community support not found anywhere else in the state. OHSU serves patients from every corner of Oregon and is a conduit for learning for more than 4,400 students and trainees. OHSU is the source of more than 200 community outreach programs that bring health and education services to each county in the state.